Free Trial

Trellus Health (TRLS) Competitors

GBX 0.73 -0.07 (-8.38%)
As of 06/13/2025 10:55 AM Eastern

TRLS vs. IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, COG, and INHC

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), and Induction Healthcare Group (INHC). These companies are all part of the "health information services" industry.

Trellus Health vs. Its Competitors

IQ-AI (LON:IQAI) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, valuation, community ranking, analyst recommendations, earnings, institutional ownership, risk, dividends and media sentiment.

IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-77.52% -140.75% -22.03%
Trellus Health -12,114.55%-37.95%-22.76%

IQ-AI received 6 more outperform votes than Trellus Health when rated by MarketBeat users.

CompanyUnderperformOutperform
IQ-AIOutperform Votes
6
66.67%
Underperform Votes
3
33.33%
Trellus HealthN/AN/A

IQ-AI has higher revenue and earnings than Trellus Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K3.30N/AN/AN/A
Trellus Health£65.83K21.53-£7.98M-£3.45-0.21

IQ-AI has a beta of 2.25, meaning that its share price is 125% more volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500.

In the previous week, IQ-AI's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
IQ-AI Neutral
Trellus Health Neutral

19.3% of Trellus Health shares are held by institutional investors. 66.0% of IQ-AI shares are held by insiders. Comparatively, 49.7% of Trellus Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

IQ-AI beats Trellus Health on 6 of the 10 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£1.42M£210.66M£5.57B£2.91B
Dividend YieldN/A6.68%5.27%4.90%
P/E Ratio-0.21310.3526.75124.60
Price / Sales21.53235.17404.17248,064.88
Price / Cash0.7647.1438.2528.07
Price / Book0.085.366.964.64
Net Income-£7.98M-£15.55M£3.23B£5.91B
7 Day Performance-18.65%-1.16%-1.22%6.61%
1 Month Performance-57.63%-2.23%6.34%13.53%
1 Year Performance-56.88%3.64%33.05%78.98%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 0.73
-8.4%
N/A-56.9%£1.42M£65.83K-0.2131Gap Down
IQAI
IQ-AI
N/AGBX 0.80
flat
N/AN/A£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
2.4924 of 5 stars
GBX 2,020
+1.5%
GBX 2,800
+38.6%
-15.7%£867.93M£230.77M74.63734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500News Coverage
KOO
Kooth
2.8737 of 5 stars
GBX 167
-1.8%
GBX 456.67
+173.5%
-44.8%£61.29M£50.72M15.69478Positive News
RENX
Renalytix
N/AGBX 7.20
-0.7%
N/A-63.3%£29.85M£9.22M-0.34102
COG
Cambridge Cognition
N/AGBX 37.60
+0.3%
N/A-13.8%£15.74M£15.64M-9.9980Gap Up
INHC
Induction Healthcare Group
N/AGBX 9.70
-0.5%
N/A-23.2%£8.95M£12.57M-1.7574

Related Companies and Tools


This page (LON:TRLS) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners